chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, SARS-CoV-2 test
Clinical narrative: Body aches; Body chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955), via an unspecified route of administration in the left arm on 22Mar2021 at 09:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included kidney stones. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received tramadol (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 (reported as after 6 days), after receiving vaccine, the patient started experiencing body chills, headache and body aches. The patient still had chills off and on. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test on 28Mar2021 which included nasal swab and the test result was negative. The patient did not receive any treatment for the events body chills, headache and body aches. The clinical outcome of the events chills, headache and general body pain were recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Nasopharyngitis, Pain, Pyrexia
Clinical narrative: Cold symptoms; Chills; Fever of 101.5; Body ache; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: er8727), via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 47-years-old) at 09:45 as a single dose for COVID-19 immunisation. Medical history included obesity. The patient had no allergies to medications, food and other products. Concomitant medications included daily vitamin (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), and digestive enzymes (MANUFACTURER UNKNOWN) all from unknown date for unknown indication. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 28Mar2021 at 08:00, the patient experienced cold symptoms, chills, fever of 101.5 (unspecified units), body ache, and slight headache. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the adverse events. The clinical outcome of the events cold symptoms, chills, fever of 101.5, body ache and slight headache were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Fever; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 24Mar2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient previously received rizatriptan benzoate (MAXALT) and was allergic. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 02Mar2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, the patient experienced fever, chills and fatigue. The adverse events had not resulted in doctor or other healthcare professional office/clinic visit/ emergency visit/ department or urgent care. Therapeutic measures and treatments were not taken as a result of fever, chills and fatigue. The clinical outcome of the events fever and chills was resolved on an unspecified date in Mar2021 and fatigue recovered on 26Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Papule
Clinical narrative: Lump on lower lip, left hand corner...cover 1/3 of that side.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER261) via unspecified route of administration in the left arm on 27Mar2021at 11:30 (at the age 63 -years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included ziprasidone 80 mg (MANUFACTURER UNKNOWN) from unknown date for unknown indication, buspirone 15 mg (MANUFACTURER UNKNOWN) from unknown date for unknown indication and bupropion 200 mg (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not known allergies to medications, food, or other products. On 29Mar2021 the patient experienced lump on lower lip, left hand corner. the events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for events. The clinical outcome of lump on lower lip, left hand corner resolving at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Viral test
Clinical narrative: metal taste in my mouth all the time, not getting better, getting worse; This is a spontaneous report received from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine, Lot number: EL1284) via an unspecified route of administration in the right arm on 13Jan2021 at 15:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included essential tremors, gastroesophageal reflux disease (GERD) and anxiety. The patient did not have any known allergies to medications, food, or other products. Concomitant medications included propranolol (MANUFACTURER UNKNOWN), valacyclovir (MANUFACTURER UNKNOWN), vitamin D NOS (MANUFACTURER UNKNOWN), vitamin B12 NOS (MANUFACTURER UNKNOWN) and iron (MANUFACTURER UNKNOWN) all taken for unknown indications from unknown date. The patient previously received first dose of BNT162b2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: EJ1685) via an unspecified route of administration in the right arm on 23Dec2020 at 08:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Jan2021, the patient experienced metallic taste in her mouth all the time which was not getting better and was getting worse. The patient had nasal swab test on 22Mar2021 and resulted negative. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event metallic taste. The clinical outcome of the event metallic taste was not resolved at the time of this report.   No follow up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cold sweat, Decreased appetite, Fatigue, Headache
Clinical narrative: Chest tightening; Muscle Tightening; Nausea; Cold Sweats; Loss of Appetite; fatigue; headache; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old, female patient received first dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 23Mar2021 at 10:45 (at the age of 47-yeasr-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as high blood pressure, kidney and gallstones, depression, and bladder tumor. Concomitant medications were reported (unspecified drug). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 28Mar2021 at 05:00, the patient experienced chest tightening, headache, nausea, cold sweats, muscle tightening - type headache, loss of appetite and fatigue. The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the events chest tightening, headache, nausea, cold sweats, muscle tightening, loss of appetite and fatigue was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Nausea
Clinical narrative: Chest tightening; Muscle Tightening; Nausea; Cold Sweats; Loss of Appetite; fatigue; headache; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old, female patient received first dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 23Mar2021 at 10:45 (at the age of 47-yeasr-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as high blood pressure, kidney and gallstones, depression, and bladder tumor. Concomitant medications were reported (unspecified drug). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 28Mar2021 at 05:00, the patient experienced chest tightening, headache, nausea, cold sweats, muscle tightening - type headache, loss of appetite and fatigue. The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the events chest tightening, headache, nausea, cold sweats, muscle tightening, loss of appetite and fatigue was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; tiredness; Chills; Feverish feeling; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the left arm on 27Mar2021 at 14:30 (at the age of 69-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin and pollen allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the left arm on 06Mar2021 at 14:15 (at the age of 69-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 06:00, the patient experienced injection site pain, tiredness, chills, feverish feeling and feeling unwell. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events vaccination site pain, tiredness, chills, feverish feeling and feeling unwell were resolved on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia
Clinical narrative: low grade fever and achy joints; Achy joint; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EK5730) via an unspecified route of administration in left arm on 25Mar2021 at 08:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient' did not take any concomitant medication. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 18:00, the patient experienced low grade fever and achy joints. The patient did not receive any treatment for events reported. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events, low grade fever and achy joints was recovered.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in left arm at injection site.; This is a spontaneous report from a contactable consumer via Pfizer sales/company representative, the parent. A 25-year-old-non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Mar2021 at 12:00, the patient experienced soreness in left arm at injection site. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event vaccination site pain. The clinical outcome of the event vaccination site pain was recovering at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in arm at injection site; This is a spontaneous report from a contactable consumer via Pfizer sales/company representative. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27Mar2021 at 13:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol which is controlled via unknown medication. The patient did not have any allergies to food, medications, or other products. Concomitant medication included rosuvastatin (MANUFACTURER UNKNOWN) 10 mg/day for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Mar2021 at 19:00, the patient experienced soreness in arm at injection site. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event vaccination site pain. The clinical outcome of the event vaccination site pain was recovering at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hyperhidrosis, Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: Dose 1 at 11Mar2021 and Dose 2 at 25Mar2021; Chills; Fever; Aching legs; sore arm where shot was given; sweating; This is a spontaneous report from a contactable consumer. A-50-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: er8727) via unspecified route of administration in the left arm on 25Mar2021 at 10:45hrs (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no known allergies to medications, food or other products. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: en6205) via unspecified route of administration in the left arm on 11Mar2021 at 10:30hrs(at the age of 50-years-old) as a single dose for COVID -19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination.  The patient had not been tested for COVID-19 since having the vaccine. The patient received first dose on 11Mar2021 and second dose on 25Mar2021 (inappropriate schedule of vaccine administered). On 26Mar2021, at 02:00, the patient experienced chills, fever, aching legs, sweating and sore arm where shot was given. The patient underwent lab tests and procedures, which included body temperature and the temperature was 99.2 F. Therapeutic measures were taken and included treatment himself with Tylenols . The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the chills, fever, aching legs, sore arm and sweating was recovered on unknown date and of the inappropriate schedule of vaccine administered was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Dose 1 at 11Mar2021 and Dose 2 at 25Mar2021; Chills; Fever; Aching legs; sore arm where shot was given; sweating; This is a spontaneous report from a contactable consumer. A-50-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: er8727) via unspecified route of administration in the left arm on 25Mar2021 at 10:45hrs (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no known allergies to medications, food or other products. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: en6205) via unspecified route of administration in the left arm on 11Mar2021 at 10:30hrs(at the age of 50-years-old) as a single dose for COVID -19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination.  The patient had not been tested for COVID-19 since having the vaccine. The patient received first dose on 11Mar2021 and second dose on 25Mar2021 (inappropriate schedule of vaccine administered). On 26Mar2021, at 02:00, the patient experienced chills, fever, aching legs, sweating and sore arm where shot was given. The patient underwent lab tests and procedures, which included body temperature and the temperature was 99.2 F. Therapeutic measures were taken and included treatment himself with Tylenols . The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the chills, fever, aching legs, sore arm and sweating was recovered on unknown date and of the inappropriate schedule of vaccine administered was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Swelling, Vaccination site erythema
Clinical narrative: swollen right armpit; redness around injection site which the skin was hot to the touch; headache; body aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the right arm on 25Mar2021 at 13:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318), via an unspecified route of administration in the right arm on 04Mar2021 at 11:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 18:00, after the second dose, the patient experienced headache and body aches which started by the evening. On 27Mar2021, the patient experienced swollen right armpit and redness around injection site which the skin was hot to the touch. The patient continued to feel body aches. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, body aches, swollen right armpit and redness around injection site were resolved on 28Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain in extremity
Clinical narrative: Arm was pretty sore; Headaches off and on. Constant dull pain with some intermittent sharp pains around temples/side of head.; felt a bit tired and lightheaded about 2hours after vaccination.; felt a bit tired and lightheaded about 2hours after vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the arm left on 27Mar2021 at 10:15 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), seasonal allergy and pet allergy. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), quercetin (MANUFACTURER UNKNOWN), PRENATAL, vitex agnus-castus extract (BIOFEM PMS) and 5-Hydroxytryptophan (MANUFACTURER UNKNOWN); all for unknown indications. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 27Mar2021 at 12:00, the patient felt a bit tired and lightheaded about 2 hours after vaccination, and her arm was pretty sore on the day of vaccination and the day after she had difficult to reach above shoulder. The patient also experienced headaches off and-on and constant dull pain with some intermittent sharp pains around temples/side of head. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tiredness, light-headed, pain in arm and headache was resolved on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Migraine, Neck pain, Pain in jaw
Clinical narrative: achey head; achey  jaw; neck leadingto migraine; Tired; achey neck; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: er8732) via unspecified route of administration in the left arm on 24Mar2021 at 15:45 (at the age 51 -years-old), as a single dose for COVID-19 immunisation. Medical history included migraine. Concomitant medications included Ibuprofen (ADVIL), loratadine;pseudoephedrine sulfate (CLARITIN-D) and women's daily vitamins (MANUFACTURER UNKNOWN), from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 19:30, the patient experienced tired, achey head, jaw, neck leading to migraine which lasted 3 days. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient receive treatment with IMITREX for the adverse event migraine. The clinical outcome of the events tired, headache, neck pain and jaw pain were resolving while neck leading to migraine recovered on 27Mar2021 (third day) at the time of report.    No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Strange chemical or metallic odor; This is a spontaneous report from a contactable consumer, the patient. A 57-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in left arm on 23Mar2021 at 16:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient medical history included Hashimotos thyroid, menopausal symptoms and arthritis. The patient had allergic to unspecified medications, food or other products. Concomitant medications included vitamin d(MANUFACTURER UNKNOWN), Estradiol (ESTROGEN), levothyroxine sodium (SYNTHYROID), progesterone(MANUFACTURER UNKNOWN) and cele (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 25Mar2021 at 12:00, 2 days after the shot the patient experienced a strange chemical or metallic odor which occurred on a regular basis which did not depend on location, air movement, or temperature and was not affected by sense of taste but only by smell. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the event  metallic smell was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Polymerase chain reaction
Clinical narrative: Eye twitch in left eye bottom lid; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the left arm on 08Mar2021 at 13:45 (at the age of 19-year-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN2613) via an unspecified route of administration in the left arm on 29Mar2021 at 13:45 (at the age of 19-year- old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included microgestin (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 08Mar2021 at 13:45, patient experienced eye twitch in the left eye bottom lid all day and every day. It started the day, when patient got first dose. The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event eyelid twitching was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Arteriosclerosis, Asthenia, Bone disorder, Impaired work ability
Clinical narrative: urinary tract infection; sore arm; limited her ability to do things; angiogram showed mild blockage; progressively been getting weaker/weakness; bones periodically get icy cold; had heavy breathing which was difficult to control even with her focusing on her breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient).  An 85-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EN6201; Expiration Date: unknown), dose 2 via an unspecified route of administration, administered in Deltoid Left on 17Feb2021 at 03:00 as dose 2, single for COVID-19 immunisation. Medical history included atrial fibrillation. The patient's concomitant medications were not reported. The patient previously took BNT162B2 for covid-19 immunisation and experienced asthenia on 30Jan2021. Relevant medical history and concurrent conditions included a fib. The patient has allergy to iodine. The patient did not receive prior vaccinations within 4 weeks. The patient did not receive any prior vaccinations within 4 weeks of receiving covid-19 vaccine. The patient has been keeping a daily journal for over 20 years and she noticed a trend of her symptoms after the vaccines. On 29Mar2021, the patient experienced progressively been getting weaker/weakness, a feeling from the top of her head to her knees. In Mar2021, the patient experienced bones periodically get icy cold. On an unknown date, had heavy breathing which was difficult to control even with her focusing on her breathing; on an unspecified date, the patient experienced sore arm, urinary tract infection, limited her ability to do things and on 22Mar2021, the patient experienced angiogram showed mild blockage, so it does not require surgery. The patient knows there have been reports of body aches then you could say sensations numbness, tingling, etcetera. The patient wakes up and is good for about an hour at most and then she gets weakness. The patient went by ambulance to the emergency room on 1Mar2021, due to the weakness and was out on same day. The patient underwent lab test which included, COVID-19 virus test which was negative on 01Mar2021. On 22Mar2021 Angiogram showed mild blockage. On an unknown date, the white blood cell count was normal. Therapeutic measures were taken with a bag of Rocephin. The patient was on a recording monitor and it sends reports to her cardiologist every night and it has not noted an event in over 90 days. The clinical outcome of the events progressively been getting weaker/weakness was not recovered; bones periodically get icy cold, sore arm, angiogram showed mild blockage, had heavy breathing which was difficult to control even with her focusing on her breathing, limited her ability to do things urinary tract infection was unknown.  No follow-up attempts needed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021633718 similar report from same reporter
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Respiratory rate increased, SARS-CoV-2 test, Urinary tract infection, White blood cell count
Clinical narrative: urinary tract infection; sore arm; limited her ability to do things; angiogram showed mild blockage; progressively been getting weaker/weakness; bones periodically get icy cold; had heavy breathing which was difficult to control even with her focusing on her breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient).  An 85-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EN6201; Expiration Date: unknown), dose 2 via an unspecified route of administration, administered in Deltoid Left on 17Feb2021 at 03:00 as dose 2, single for COVID-19 immunisation. Medical history included atrial fibrillation. The patient's concomitant medications were not reported. The patient previously took BNT162B2 for covid-19 immunisation and experienced asthenia on 30Jan2021. Relevant medical history and concurrent conditions included a fib. The patient has allergy to iodine. The patient did not receive prior vaccinations within 4 weeks. The patient did not receive any prior vaccinations within 4 weeks of receiving covid-19 vaccine. The patient has been keeping a daily journal for over 20 years and she noticed a trend of her symptoms after the vaccines. On 29Mar2021, the patient experienced progressively been getting weaker/weakness, a feeling from the top of her head to her knees. In Mar2021, the patient experienced bones periodically get icy cold. On an unknown date, had heavy breathing which was difficult to control even with her focusing on her breathing; on an unspecified date, the patient experienced sore arm, urinary tract infection, limited her ability to do things and on 22Mar2021, the patient experienced angiogram showed mild blockage, so it does not require surgery. The patient knows there have been reports of body aches then you could say sensations numbness, tingling, etcetera. The patient wakes up and is good for about an hour at most and then she gets weakness. The patient went by ambulance to the emergency room on 1Mar2021, due to the weakness and was out on same day. The patient underwent lab test which included, COVID-19 virus test which was negative on 01Mar2021. On 22Mar2021 Angiogram showed mild blockage. On an unknown date, the white blood cell count was normal. Therapeutic measures were taken with a bag of Rocephin. The patient was on a recording monitor and it sends reports to her cardiologist every night and it has not noted an event in over 90 days. The clinical outcome of the events progressively been getting weaker/weakness was not recovered; bones periodically get icy cold, sore arm, angiogram showed mild blockage, had heavy breathing which was difficult to control even with her focusing on her breathing, limited her ability to do things urinary tract infection was unknown.  No follow-up attempts needed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021633718 similar report from same reporter
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lymph node pain, Lymphadenopathy, Neck pain
Clinical narrative: Minimal pain innodes under right arm; Pain in neck.; Very painful, swollen lymph nodes under the left arm.; Pain in left.; Pain in shoulder.; headache; fever; body aches; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 11:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos thyroiditis. Concomitant medications included T3 and T4 thyro meds (medicines). The patient had known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021 at 21:00, the patient experienced very painful, swollen lymph nodes under the left arm. There was minimal pain in the nodes under the right arm. The patient also had pain in the left arm, neck and shoulder. Then the patient experienced headache, fever and body aches for two days following injection. It was reported that lymph nodes under the left arm were still swollen. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included the treatment with ibuprofen. The clinical outcome of headache, fever and body aches was recovered on 28Mar2021; while the outcome for painful swollen lymph nodes under the left arm, painful nodes under right arm, pain in left arm, neck, and shoulder were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Minimal pain innodes under right arm; Pain in neck.; Very painful, swollen lymph nodes under the left arm.; Pain in left.; Pain in shoulder.; headache; fever; body aches; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 11:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos thyroiditis. Concomitant medications included T3 and T4 thyro meds (medicines). The patient had known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021 at 21:00, the patient experienced very painful, swollen lymph nodes under the left arm. There was minimal pain in the nodes under the right arm. The patient also had pain in the left arm, neck and shoulder. Then the patient experienced headache, fever and body aches for two days following injection. It was reported that lymph nodes under the left arm were still swollen. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included the treatment with ibuprofen. The clinical outcome of headache, fever and body aches was recovered on 28Mar2021; while the outcome for painful swollen lymph nodes under the left arm, painful nodes under right arm, pain in left arm, neck, and shoulder were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Head discomfort, Headache
Clinical narrative: Extreme fatigue continuing  1st,3rd.5th and 7th day after 2nd shot.  Every time I thought I was recovering, the extreme fatigue came back the next day.; Fuzzy head; Headaches on and off; Pressure inthe head with the fatigue. ( no temperature); This is a spontaneous report from a contactable consumer, the patient. A 88-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 88-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient included hypothyroidism, and unspecified penicillin allergy. Concomitant medication included levothyroxine sodium (SYNTHROID) for hypothyroidism from an unknown date. The patient previously received aspirin (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the left arm on 02Mar2021 at 14:00 (at the age of 88-years old). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021, at 10:00, the patient experienced event extreme fatigue which continued on the 1st, 3rd, 5th and 7th day after the second dose of vaccination (on 23Mar2021). Every time, the patient thought she was recovering, and an extreme fatigue came back the next day. On the same day at 10:00, the patient had very fuzzy head, headaches on and off and pressure in the head with the fatigue (no temperature). The patient did not receive any treatment for the reported events. The clinical outcomes of the events extreme fatigue, very fuzzy head, headache on and off and pressure in the head were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: Chills; headache; fatigue; body aches; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8730) via an unspecified route of administration in left arm on 26Mar2021 at 12:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history reported as none. The patient had no allergy to any medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other medications within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: EN6205) via an unspecified route of administration in the left arm on 05Mar2021 at 09:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 27Mar2021, at 01:30, the patient experienced chills, headache (appeared to be mainly in sinuses), body aches, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events chills, headache (appeared to be mainly in sinuses), body aches and fatigue were resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling hot, Hyperhidrosis, Migraine
Clinical narrative: the migraine continued along with fatigue,slept, joint aches, fever, sweats andrestless sleep.; the migraine continued along with fatigue,slept, joint aches, fever, sweats andrestless sleep.; the migraine continued along with fatigue,slept, joint aches, fever, sweats andrestless sleep.; the migraine continued along with fatigue,slept, joint aches, fever, sweats andrestless sleep.; the migraine continued along with fatigue,slept, joint aches, fever, sweats andrestless sleep.; the migraine continued along with fatigue,slept, joint aches, fever, sweats andrestless sleep.; I got really hot after thefirst 15 minutes which followed by amigraine headache; I got really hot after thefirst 15 minutes which followed by amigraine headache; This is a spontaneous report from a contactable consumer, the patient. A 51-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: ep6955), via an unspecified route of administration in the left arm on 27Mar2021 at 14:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Patient had previously had sulfur (MANUFACTURER UNKNOWN), azithromycin (MANUFACTURER UNKNOWN), nuts and pineapples and experienced allergy to sulfur (MANUFACTURER UNKNOWN), azithromycin (ZITHROMAX), nuts and pineapples. Previously the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: en6205), via an unspecified route of administration in the right arm on 06Mar2021 at 15:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation and had no side effects.. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 27Mar2021 at 14:45, 15 minutes after vaccination, the patient experienced feeling hot and migraine headache. After the second dose she got really hot after first 15 minutes which was followed by a migraine headache. The next day, on 28Mar2021, migraine continued along with fatigue, slept, joint aches, fever, sweats and restless sleep. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcomes of feeling hot, migraine headache, fatigue, slept, joint aches, fever, sweats and restless sleep were resolving.   No follow-up attempts are needed. No further information is expected.